Terbinafine-loaded branched PLGA-based cationic nanoparticles with modifiable properties

References

• Alizadeh AM, Sadeghizadeh M, Najafi F, Ardestani SK, Erfani-Moghadam V, Khaniki M, Rezaei A, Zamani M, Khodayari S, Khodayari H, et al. 2015. Encapsulation of curcumin in diblock copolymer micelles for cancer therapy. BioMed Res Int. 2015:1.
   Web of Science ®Google Scholar
• Almoustafa HA, Alshawsh MA, Chik Z. 2017. Technical aspects of preparing PEG-PLGA nanoparticles as carrier for chemotherapeutic agents by nanoprecipitation method. Int J Pharm. 533(1):275–284.
   PubMedGoogle Scholar
• Awotwe-Otoo D, Zidan AS, Rahman Z, Habib MJ. 2012. Evaluation of anticancer drug-loaded nanoparticle characteristics by nondestructive methodologies. AAPS PharmSciTech. 13(2):611–622.
   PubMed Web of Science ®Google Scholar
• Balouiri M, Sadiki M, Ibnsouda SK. 2016. Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal. 6(2):71–79.
   PubMed Web of Science ®Google Scholar
• Bell‐Syer SEM, Khan SM, Torgerson DJ. 2012. Oral treatments for fungal infections of the skin of the foot. Cochrane Database Syst Rev. 10:CD003584.
   PubMedGoogle Scholar
• Blasi P, D'Souza SS, Selmin F, DeLuca PP. 2005. Plasticizing effect of water on poly(lactide-co-glycolide). J Control Release. 108(1):1–9.
   PubMed Web of Science ®Google Scholar
• Budhian A, Siegel SJ, Winey KI. 2008. Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles. Int J Pharm. 346(1/2):151–159.
   PubMedGoogle Scholar
• Chourasiya V, Bohrey S, Pandey A. 2016. Formulation, optimization, characterization and in-vitro drug release kinetics of atenolol loaded PLGA nanoparticles using 33 factorial design for oral delivery. Mater Discover. 5:1–13.
   Google Scholar
• Chu KS, Schorzman AN, Finniss MC, Bowerman CJ, Peng L, Luft JC, Madden AJ, Wang AZ, Zamboni WC, DeSimone JM. 2013. Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy. Biomaterials. 34(33):8424–8429.
   PubMed Web of Science ®Google Scholar
• Clayton KN, Salameh JW, Wereley ST, Kinzer-Ursem TL. 2016. Physical characterization of nanoparticle size and surface modification using particle scattering diffusometry. Biomicrofluidics. 10(5):054107–054107.
   PubMed Web of Science ®Google Scholar
• Darestani MT, Entezami AA, Mobedi H, Abtahi M. 2005. Degradation of Poly(d,l-lactide-co-glycolide) 50:50 implant in aqueous medium. Iran Polym J. 14(8):753–763.
   Web of Science ®Google Scholar
• Das S, Suresh PK, Desmukh R. 2010. Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomed Nanotechnol Biol Med. 6(2):318–323.
   PubMed Web of Science ®Google Scholar
• Esfandyari-Manesh M, Ghaedi Z, Asemi M, Khanavi M, Manayi A, Jamalifar H, Atyabi F, Dinarvand R. 2013. Study of antimicrobial activity of anethole and carvone loaded PLGA nanoparticles. J Pharm Res. 7(4):290–295.
   Google Scholar
• Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. 1989. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm. 55(1):R1–R4.
   Web of Science ®Google Scholar
• Fredenberg S, Wahlgren M, Reslow M, Axelsson A. 2011. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems – a review. Int J Pharm. 415(1/2):34–52.
   PubMedGoogle Scholar
• Fu Y, Kao WJ. 2010. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin Drug Deliv. 7(4):429–444.
   PubMed Web of Science ®Google Scholar
• Gianni C. 2010. Update on antifungal therapy with terbinafine. G Ital Dermatol Venereol. 145(3):415–424.
   PubMed Web of Science ®Google Scholar
• Gossmann R, Spek S, Langer K, Mulac D. 2018. Didodecyldimethylammonium bromide (DMAB) stabilized poly(lactic-co-glycolic acid) (PLGA) nanoparticles: uptake and cytotoxic potential in Caco-2 cells. J Drug Deliv Sci Technol. 43:430–438.
   Web of Science ®Google Scholar
• Güngör S, Erdal MS, Aksu B. 2013. New formulation strategies in topical antifungal therapy. JCDSA. 03(01):56.
   Google Scholar
• Guterres SS, Alves MP, Pohlmann AR. 2007. Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications. Drug Target Insights. 2:147–157.
   PubMedGoogle Scholar
• Huang X, Brazel CS. 2001. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release. 73(2/3):121–136.
   PubMed Web of Science ®Google Scholar
• Hughes JM, Budd PM, Grieve A, Dutta P, Tiede K, Lewis J. 2015. Highly monodisperse, lanthanide-containing polystyrene nanoparticles as potential standard reference materials for environmental ‘nano’ fate analysis. J Appl Polym Sci. 132(24):42061(1–9).
   Web of Science ®Google Scholar
• Jelvehgari M, Hassanzadeh D, Kiafar F, Delf Loveym B, Amiri S. 2011. Preparation and determination of drug-polymer interaction and in-vitro release of mefenamic acid microspheres made of celluloseacetate phthalate and/or ethylcellulose polymers. Iran J Pharm Res. 10(3):457–467.
   PubMed Web of Science ®Google Scholar
• Liu W, Bertrand M, Chaneac C, Achouak W. 2016. TiO2 nanoparticles alter iron homeostasis in Pseudomonas brassicacearum as revealed by PrrF sRNA modulation. Environ Sci: Nano. 3(6):1473–1482.
   Web of Science ®Google Scholar
• Martín-Banderas L, Alvarez-Fuentes J, Durán-Lobato M, Prados J, Melguizo C, Fernández-Arévalo M, Holgado MÁ. 2012. Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies. Int J Nanomed. 7:5793–5806.
   PubMed Web of Science ®Google Scholar
• Mendes AI, Silva AC, Catita JAM, Cerqueira F, Gabriel C, Lopes CM. 2013. Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity. Colloids Surf B. 111:755–763.
   PubMed Web of Science ®Google Scholar
• Mora-Huertas CE, Fessi H, Elaissari A. 2010. Polymer-based nanocapsules for drug delivery. Int J Pharm. 385(1/2):113–142.
   PubMedGoogle Scholar
• Moraes Moreira Carraro TC, Altmeyer C, Maissar Khalil N, Mara Mainardes R. 2017. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles. J Mycol Med. 27(4):519–529.
   PubMed Web of Science ®Google Scholar
• Musumeci T, Ventura CA, Giannone I, Ruozi B, Montenegro L, Pignatello R, Puglisi G. 2006. PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm. 325(1/2):172–179.
   PubMedGoogle Scholar
• Palacio J, Orozco VH, López BL. 2011. Effect of the molecular weight on the physicochemical properties of poly(lactic acid) nanoparticles and on the amount of ovalbumin adsorption. J Braz Chem Soc. 22:2304–2311.
   Web of Science ®Google Scholar
• Panyam J, Williams D, Dash A, Leslie-Pelecky D, Labhasetwar V. 2004. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J Pharm Sci. 93(7):1804–1814.
   PubMed Web of Science ®Google Scholar
• Peppas NA, Narasimhan B. 2014. Mathematical models in drug delivery: how modeling has shaped the way we design new drug delivery systems. J Control Release. 190:75–81.
   PubMed Web of Science ®Google Scholar
• Pirooznia N, Hasannia S, Lotfi AS, Ghanei M. 2012. Encapsulation of alpha-1 antitrypsin in PLGA nanoparticles: in vitro characterization as an effective aerosol formulation in pulmonary diseases. J Nanobiotechnol. 10:20–20.
   PubMed Web of Science ®Google Scholar
• Puttipipatkhachorn S, Nunthanid J, Yamamoto K, Peck GE. 2001. Drug physical state and drug–polymer interaction on drug release from chitosan matrix films. J Control Release. 75(1/2):143–153.
   PubMed Web of Science ®Google Scholar
• Serajuddin AT, Mufson D. 1985. pH-solubility profiles of organic bases and their hydrochloride salts. Pharm Res. 2(2):65–68.
   PubMedGoogle Scholar
• Snejdrova E, Podzimek S, Martiska J, Holas O, Dittrich M. 2019. Branched PLGA derivatives with tailored drug delivery properties. Acta Pharm. [accessed 2019 March 20]:[13 p.]. http://acta.pharmaceutica.farmaceut.org/Snejdrova.pdf.
   Google Scholar
• Sun SB, Liu P, Shao FM, Miao QL. 2015. Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer. Int J Clin Exp Med. 8(10):19670–19681.
   PubMed Web of Science ®Google Scholar
• Sun XG, Wang ZX, Wang ZQ, Deng SJ, Li R, Luo SY, Wu YY. 2007. Pharmacokinetics of terbinafine in the rabbit ocular tissues after topical administration. Ophthalmic Res. 39(2):81–83.
   PubMed Web of Science ®Google Scholar
• Teixeira M, Alonso MJ, Pinto MMM, Barbosa CM. 2005. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. Eur J Pharm Biopharm. 59(3):491–500.
   PubMed Web of Science ®Google Scholar
• Tubic-Grozdanis M, Bolger MB, Langguth P. 2008. Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds. AAPS J. 10(1):213–226.
   PubMed Web of Science ®Google Scholar
• Verwey E. 1947. Theory of the stability of lyophobic colloids. J Phys Colloid Chem. 51(3):631–636.
   PubMedGoogle Scholar
• Wang J, Yin Z, Xue X, Kundu CS, Mo X, Lu S. 2016. Natural non-mulberry silk nanoparticles for potential-controlled drug release. IJMS. 17(12):2012.
   Google Scholar
• Wang Y, Li P, Truong-Dinh Tran T, Zhang J, Kong L. 2016. Manufacturing techniques and surface engineering of polymer-based nanoparticles for targeted drug delivery to cancer. Nanomaterials. 6(2):26.
   Web of Science ®Google Scholar
• Wang Y, Tan Y. 2016. Enhanced drug loading capacity of 10-hydroxycamptothecin-loaded nanoparticles prepared by two-step nanoprecipitation method. J Drug Deliv Sci Technol. 36:183–191.
   Web of Science ®Google Scholar